10/05/2016

Paramax Diagnostics, Inc.

PARAMAX to make its MEDICA debut featuring innovative new diagnostic analyzer for small to medium-sized diagnostic testing labs

The PMAX Combilyzer is a compact, fully automated Chemiluminesence analyzer capable of running multiple tests simultaneously

TORONTO,  Sept. 26, 2016 – PARAMAX Diagnostics Inc. will make its debut at MEDICA, the world’s largest annual medical trade fair, November 14-17 in Düsseldorf, Germany where it will introduce the patent-laden PMAX Combilyzer, a closed system in-vitro analyzer aimed at giving smaller diagnostic test labs an edge over larger competitors.

“Most diagnostic test results in centralized health care systems such as we have in Europe and North America come from large labs, which means patients may have to wait several days or more for their results while the large lab gathers enough similar samples to justify changing their machines and adjusting their procedures to make running a specific test profitable,” explains Steve Mogen, Paramax’s Business Development Manager. “But with the PMAX Combilyzer you don’t have to change machines or procedures; you can run several different tests on it all at once.”

 Mogen also points out the advantage of the Combilyzer’s multi-testing abilities in an emergency situation: “For instance, for cardiac arrest patients for whom decisions have to be made quickly, you don’t want to wait on one-at-a-time testing. For them, you want to know the results of maybe four different tests, and you want to know all the results immediately.”

 Also Mogen adds, having just one machine for a smaller lab that may only be handling 50  to 200 samples a day is very cost effective. Consequently, the PMAX Combilyzer is particularly attractive to regions such as the Middle East and Africa among others where healthcare is not centralized and therefore large labs are not economic. “In India, for example, lab tests are done by thousands of small labs spread all over the country.”

 But even in centralized healthcare jurisdictions such as Canada has in each province and territory there are advantages to the PMAX Combilyzer.

 “There are some labs where you can have online access to test results via the internet, so if the lab is using the Combilyzer that means for some physicians and their patients, they could have all their test results back in hours the same day,” says Mogen.
 
P-Max Combilyzer is approved and cleared by the FDA. It is also certified with the CE Mark, allowing its Commercial distribution in Europe as well as in all countries recognizing the CE Mark.

To learn more about PARAMAX, please visit us during MEDICA 2016 at the Ontario/Canada Pavilion, Hall 3, Booth H14.

 You can also locate us in “Companies & Products" on the medica-tradefair.com portal. 

 Contacts:

Kathy Richards

Business Developer

K.Richards@paramaxdiag.com

+1 647 476 4845

Exhibitor Data Sheet